Searching for Mushroom Extracts and Fractions with Potential Antidepressant Activity

Mental illnesses, particularly depression, are one of the leading causes of global disease burden. In addition to reducing the quality of life of patients and their relatives, they costs billions of dollars annually to the Canadian economy. Unfortunately, current antidepressant drugs are barely satisfactory and have numerous side-effects. The goal of this project is to discover potential new extracts, fraction or compound(s) with potential antidepressant activity from wild mushrooms native to British Columbia. This is in line with the objective of Translational Life Sciences (TLS) Inc., a biotechnology company based in Vancouver. TLS will have the proprietary rights to any discovered extracts, fraction or compound(s) and is therefore expected to benefit financially in the near future.

Faculty Supervisor:

Chow Lee

Student:

Partner:

Translational Life Sciences Inc

Discipline:

Life Sciences

Sector:

Professional, scientific and technical services

University:

University of Northern British Columbia

Program: